The practical implications are still emerging, but the directional trend is toward faster generic entry relative to patent expiry dates
While the official FDA labeling for Mounjaro notes that it has not been studied specifically in patients with severe gastrointestinal disease, including gastroparesis, it explicitly states that the medication is not recommended in these populations
Of note, glomerular hyperfiltration could be exacerbated by other hormonal changes associated with scarce glucose control, such as high glucagon levels [49, 51]
Low levels of glutathione can make you feel sluggish, foggy, and more reactive to stressboth physically and mentally
However, the strength of evidence for these findings was very low
Important Disclosures: Carriers are not liable for delayed or undelivered messages